Shiro Kira

1.5k total citations
54 papers, 1.0k citations indexed

About

Shiro Kira is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Shiro Kira has authored 54 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Shiro Kira's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Medical Imaging and Pathology Studies (7 papers) and Respiratory Support and Mechanisms (5 papers). Shiro Kira is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Medical Imaging and Pathology Studies (7 papers) and Respiratory Support and Mechanisms (5 papers). Shiro Kira collaborates with scholars based in Japan, United States and Singapore. Shiro Kira's co-authors include Shinichi Tanimoto, Akira Yamanaka, Yoichi Chijimatsu, Masashi Tamura, Hiomi Homma, Hiroshi Natori, Toshihiro Nukiwa, Yasuhiro Setoguchi, Simon Rodbard and Satsuki Takahashi and has published in prestigious journals such as JAMA, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Shiro Kira

54 papers receiving 995 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiro Kira Japan 17 605 223 217 180 110 54 1.0k
H Hamm Germany 19 891 1.5× 177 0.8× 275 1.3× 346 1.9× 69 0.6× 41 1.4k
B. Desrues France 18 470 0.8× 118 0.5× 221 1.0× 118 0.7× 32 0.3× 88 897
R J McGonigle United Kingdom 18 223 0.4× 144 0.6× 127 0.6× 120 0.7× 159 1.4× 52 1.1k
Nobuhiko Nagata Japan 18 684 1.1× 207 0.9× 201 0.9× 208 1.2× 22 0.2× 92 1.1k
P.A. Corris United Kingdom 15 481 0.8× 128 0.6× 304 1.4× 102 0.6× 68 0.6× 37 861
D. O’B. Hourihane Ireland 19 455 0.8× 152 0.7× 329 1.5× 164 0.9× 33 0.3× 38 1.4k
S Larsson Sweden 18 474 0.8× 71 0.3× 354 1.6× 146 0.8× 132 1.2× 40 976
V. Carnelli Italy 20 117 0.2× 92 0.4× 138 0.6× 182 1.0× 62 0.6× 53 1.3k
Masahide Yasui Japan 22 739 1.2× 359 1.6× 269 1.2× 558 3.1× 50 0.5× 85 1.4k
John B. Blennerhassett New Zealand 16 597 1.0× 48 0.2× 275 1.3× 110 0.6× 91 0.8× 43 1.1k

Countries citing papers authored by Shiro Kira

Since Specialization
Citations

This map shows the geographic impact of Shiro Kira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiro Kira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiro Kira more than expected).

Fields of papers citing papers by Shiro Kira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiro Kira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiro Kira. The network helps show where Shiro Kira may publish in the future.

Co-authorship network of co-authors of Shiro Kira

This figure shows the co-authorship network connecting the top 25 collaborators of Shiro Kira. A scholar is included among the top collaborators of Shiro Kira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiro Kira. Shiro Kira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ohnishi, Masahiro, Masahiko Oka, Masashi Muramatsu, et al.. (1999). E4021, a Selective Phosphodiesterase 5 Inhibitor, Potentiates the Vasodilator Effect of Inhaled Nitric Oxide in Isolated Perfused Rat Lungs. Journal of Cardiovascular Pharmacology. 33(4). 619–624. 7 indexed citations
3.
Miyamoto, Kenji, et al.. (1998). Prognostic Value of Hypercapnia in Patients with Chronic Respiratory Failure during Long-term Oxygen Therapy. American Journal of Respiratory and Critical Care Medicine. 158(1). 188–193. 69 indexed citations
5.
Kira, Shiro, et al.. (1996). Disintegration of the ‘waterfall phenomenon’ in the inferior vena cava due to right heart failure. Respirology. 1(1). 5–9. 1 indexed citations
6.
Takahashi, Hideki, Kazumi Ishidoh, Akihiko Ohwada, et al.. (1993). Cathepsin L Activity Is Increased in Alveolar Macrophages and Bronchoalveolar Lavage Fluid of Smokers. American Review of Respiratory Disease. 147(6_pt_1). 1562–1568. 53 indexed citations
7.
Tamura, Naoaki, et al.. (1992). [A case of hypersensitivity pneumonitis due to isocyanate exposure showing progression even two months after removal of the antigen].. PubMed. 30(3). 458–63. 5 indexed citations
8.
Saito, Hiroyuki, et al.. (1992). Evaluation of Cor Pulmonale on a Modified Short-axis Section of the Heart by Magnetic Resonance Imaging. American Review of Respiratory Disease. 146(6). 1576–1581. 29 indexed citations
9.
Ohwada, Akihiko, et al.. (1992). Gene Analysis of Heterozygous Protein C Deficiency in a Patient with Pulmonary Arterial Thromboembolism. American Review of Respiratory Disease. 145(6). 1491–1494. 11 indexed citations
10.
Muramatsu, Masashi, et al.. (1992). [A case of mediastinal lymphatic cyst possibly originating from the right thoracic duct].. PubMed. 30(6). 1136–40. 2 indexed citations
11.
Setoguchi, Yasuhiro, Satsuki Takahashi, Toshihiro Nukiwa, & Shiro Kira. (1991). Detection of Human T-Cell Lymphotropic Virus Type I-related Antibodies in Patients with Lymphocytic Interstitial Pneumonia. American Review of Respiratory Disease. 144(6). 1361–1365. 34 indexed citations
12.
Takahashi, Satsuki, Yasuhiro Setoguchi, Toshihiro Nukiwa, & Shiro Kira. (1991). Soluble lnterleukin-2 Receptor in Sera of Patients with Pulmonary Tuberculosis. CHEST Journal. 99(2). 310–314. 32 indexed citations
13.
Nagai, Hideaki, et al.. (1991). Sequential Changes of Perivascular Edema Cuffs in Models of Permeability and Hemodynamic Pulmonary Edema. Respiration. 58(1). 57–61. 4 indexed citations
14.
Watanabe, Shuichi, Satoshi Kitamura, Takeshi Yokoyama, & Shiro Kira. (1990). Clinicopathological characteristics of autopsy cases of lung cancer associated with idiopathic interstitial pneumonia.. Haigan. 30(6). 841–847. 3 indexed citations
15.
Nagase, Kenichi, et al.. (1989). Two cases of hamartoangiomyomatosis with characteristic scintigraphic findings. Annals of Nuclear Medicine. 3(1). 49–54. 1 indexed citations
16.
Kira, Shiro, et al.. (1987). Estimation of personal exposure to ambient nicotine in daily environment. International Archives of Occupational and Environmental Health. 59(6). 545–550. 21 indexed citations
17.
Amemiya, Ryuta, Masahiro Kaneko, Tetsuro Kodama, et al.. (1986). Proposed new classification of bronchoscopic findings in lung cancer cases.. Haigan. 26(1). 1–10. 1 indexed citations
18.
Homma, Hiomi, Akira Yamanaka, Shinichi Tanimoto, et al.. (1983). Diffuse Panbronchiolitis. CHEST Journal. 83(1). 63–69. 308 indexed citations
20.
Kira, Shiro & Simon Rodbard. (1971). EFFECTS OF HISTAMINE AND ACETYLCHOLINE ON THE ISOLATED PERFUSED LUNG LOBE. Quarterly Journal of Experimental Physiology and Cognate Medical Sciences. 56(1). 1–11. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026